Kyowa Kirin constantly strives to bring our approach to technology and patients together by sharing our research and findings. With these materials, we aim to equip our patients and their care-givers with a better understanding of their personal journey.
Kyowa Kirin hosts Partner Appreciation Event
28 February 2023
Kyowa Kirin announces the listing of CRYSVITA® (burosumab) on the Australia’s Pharmaceuticals Benefits Scheme (PBS)
Kyowa Kirin Australia was proud to be a Gold sponsor of the ANZBMS-MEPSA-ANZORS 2022 joint annual scientific meeting
Australia’s PBAC recommends CRYSVITA® (burosumab) for listing on the PBS
XLH Australia and Kyowa Kirin Australia collaborate in first-ever, Australia-based patient impact survey.
28 February 2022
Kyowa Kirin Australia announces TGA registration of CRYSViTA® (burosumab)
Kyowa Kirin Australia sponsors XLH Symposium at 2020 ANZBMS Scientific Meeting
Japanese pharma double ticked - Pharma in Focus article
22 July 2020